InvestorsHub Logo

PoemStone

09/20/12 8:01 AM

#4897 RE: PoemStone #4896

SVNT. Savient Announces Multiple Abstracts Related to KRYSTEXXA® in the Treatment of Refractory Chronic Gout to be Presented at the 2012 ACR/ARHP Annual Meeting
http://finance.yahoo.com/news/savient-announces-multiple-abstracts-related-113000941.html